1. Pokorney SD. Low Rates Of Guideline Directed Care Associated With Higher Mortality In Patients With Infections Of Pacemakers And Implantable Cardioverter Defibrillators.American College of Cardiology (ACC) Late Breaking Clinical Trials. Washington, DC, USA April 2022 [presentation].
2. Greenspon, Arnold J., et al. “16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States1993 to 2008.” Journal ofthe American College of Cardiology 58.10 (2011): 1001-1006.
3. American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS), European Heart Rhythm Association (EHRA)
4. Lin, Andrew, et al. “Early Versus Delayed Lead Extraction in Patients with Infected Cardiovascular Implantable Electronic Device.” Moderated ePoster Presentation. 2020 HeartRhythm Society Annual Abstract Presentations Online.
5. Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoingtransvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace doi:10.1093/ europace/euu147.
6. Voigt, Andrew, et al. Rising Rates of Cardiac Rhythm Management Device Infections in the United States: 1996 through 2003. JACC Vol. 48, No. 3, 2006: 590-1.
7. Dai, Mingyan, et. al. “Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.” JACC: Clinical Electrophysiology (September2019).
8. Margey, R. et al. Contemporary management of and outcomes from cardiac device related infections Europace (2010) 12 (1): 64-70 first published online November 11, 2009doi:10.1093/ europace/eup362.
9. Voigt, Andrew, et al. Continued Rise in Rates of Cardiovascular Implantable Electronic Device Infections in the United States: Temporal Trends and Causative Insights. PACEVol. 33, No. 4, 2010: 414-9.
10. Data on file, D021403-04 Infection InfoGraphic
11. Kusumoto, et al. (2017). 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart rhythm, 14(12),e503-e551.
12. Maytin M, Jones SO, Epstein LM. Long-Term Mortality After Transvenous Lead Extraction. Circ Arrhythm Electrophysiol. 2012;5:252-257.
13. Sohail MR, Henrikson CA, Braid-Forbes M, Forbes K, Lerner DJ, Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Inern Med/Vol171 (No. 20). Nov 14, 2011.
14. Wazni, O. et. al. Lead Extraction in the Contemporary Setting: The LExICon Study: A Multicenter observational RetrospectiveStudy of Consecutive Laser Lead Extractions, J AmColl Cardiol, 55:579-586.
15. Wilkoff, B.L., et al. (1999). Pacemaker lead extraction with the laser sheath: Results of the Pacing Lead Extraction with Excimer Sheath (PLEXES) Trial. Journal of the AmericanCollege of Cardiology, 33(6).
16.Byrd, C., et al. (2002). Clinical study of the laser sheath for lead extraction: The total experience in the United States. Journal of Pacing and Electrophysiology, 25(5).23.
17. Rungpradubvong, V et al. Outcomes of early and delayed removal in patients with cardiac implantable electronic device infection. Poster Presentation. 2014 Heart RhythmSociety Annual Scientific Sessions, San Francisco, CA
18.Chua, J.D., et al. (2000). Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Annals of Internal Medicine, 133(8): 604-608.
19. Klug, D., et al. (2004). Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart, 90(8), 882-886.
20. Sohail, MR, et al. Management and outcome of permanent and implantable cardioverterdefibrillator infections. J Am Coll Cardiol. 2007;49:1851–1859
21. del Rio, A, Anguera I, Miro JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest2003;124:1451
22. Ryan Azarrafiy, BA; Darren C. Tsang, BS; Bruce L. Wilkoff, MD, FHRS; Roger G. Carrillo, MD, MBA, FHRS. The Endovascular Occlusion Balloon for Treatment of Superior VenaCava Tears During Transvenous Lead Extraction: A Multi-Year Analysis and An Update to Best Practice Protocol. Circulation: Arrhythmia and Electrophysiology, August 2019.
23. Wilkoff, B.L., et al. (2009). Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications and patient management. HeartRhythm, 6,1085-1104
24. Klug, Didier, et al. “Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections.” Journal of clinical microbiology 41.7(2003): 3348-3350.
25. Lazãr, Veronica, and C. Chifiriuc. “Medical significance and new therapeutical strategies for biofilm associated infections.” Rom Arch Microb & Immunol 69 (2010): 125-138.
26. Chen L. and Wen, Y. “The role of bacterial biofilm in persistent infections and control strategies.” Int J Oral Sci, 2011, DOI: 10.4248/IJOS11022.
27. Peacock Jr, James E., et al. “Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success?.” Pacing and ClinicalElectrophysiology 41.5 (2018): 524-531.
28. Hussein et al. Microbiology of Cardiac Implantable Electronic Device Infections. J Am CollCardiolEP 2016;2:498–505 CircArrhythmElectrophysiol.
29. Inpatient Prospective Payment System (IPPS) Final Rule FY13.
30. Centers for Medicare & Medicaid Services, US Department of Health and Human Services. Medicare Program; Hospital Inpatient Prospective Payment Systems for AcuteCare Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2013 Rates; Hospitals Resident Caps for Graduate Medical Education PaymentPurposes; Quality Reporting Requirements for Specific Providers and for Ambulatroy Surgical Centers. Baltimore, MD: Centers for Medicare & Medicaid Services; 2012. CMSpublication CMS-1588-P.
31. Difference between average hospital days from reference #20 (x) $2,157 average inpatient per day hospital cost (U.S.), which is from 1999 -2013 AHA Annual Survey,Copyright 2015 by Health Forum, LLC, an affiliate of the American Hospital Association. Special data request, 2015. Available at www.ahaonlinestore.com.
32. Paz Rios, Luis, et al. “Effect Of An Electronic Medical Alerts For Patients With Positive Cultures And Cardiovascular Implantable Electronic Devices.” Moderated ePosterPresentation. 2020 Heart Rhythm Society Annual Abstract Presentations Online.